<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
	<Article>
		<Journal>
			<PublisherName/>
			<JournalTitle>IJOTM</JournalTitle>
			<Issn>2008-6490</Issn>
			<Volume>6</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="epublish">
				<Year>2015</Year>
				<Month>10</Month>
				<Day>18</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>The Healing Effect of Adipose-Derived Mesenchymal Stem Cells in Full-thickness Femoral Articular Cartilage Defects of Rabbit</ArticleTitle>
		<FirstPage>165</FirstPage>
		<LastPage>175</LastPage>
		<Language>EN</Language>
		<AuthorList>
			<Author>
				<FirstName>D</FirstName>
				<LastName>Mehrabani</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<LastName>Babazadeh</LastName>
			</Author>
			<Author>
				<FirstName>N</FirstName>
				<LastName>Tanideh</LastName>
				<Affiliation>Stem Cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. tanidehn@gmail.com</Affiliation>
			</Author>
			<Author>
				<FirstName>S</FirstName>
				<LastName>Zare</LastName>
			</Author>
			<Author>
				<FirstName>S</FirstName>
				<LastName>Hoseinzadeh</LastName>
			</Author>
			<Author>
				<FirstName>S</FirstName>
				<LastName>Torabinejad</LastName>
			</Author>
			<Author>
				<FirstName>O</FirstName>
				<LastName>Koohi-Hosseinabadi</LastName>
			</Author>
		</AuthorList>
		<History>
			<PubDate PubStatus="received">
				<Year>2014</Year>
				<Month>08</Month>
				<Day>22</Day>
			</PubDate>
		</History>
		<Abstract>Background: Articular cartilage defect can lead to degradation of subchondral bone and osteoarthritis (OA).Objective: To determine the healing effect of transplantation of adipose-derived mesenchymal stem cells (Ad-MSCs) in full-thickness femoral articular cartilage defects in rabbit.Methods: 12 rabbits were equally divided into cell-treated and control groups. In cell-treated group, 2&amp;times;106 cells of third passage suspended in 1 mL of DMEM was injected into articular defect. The control group just received 1 mL of DMEM. Dulbecco&amp;rsquo;s modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin and streptomycin and 2 mM L-glutamine were used for cell culture. To induce cartilage defect, 4 mm articular cartilage full-thickness defect was created in the knee. For histological evaluation in each group (H&amp;amp;E, safranin-O and toluidine blue), 3 rabbits were sacrificed 4 weeks and 3 animals, 8 weeks after cell transplantation.Results: In cell therapy group post-transplantation, no abnormal gross findings were noticed. Neo-formed tissues in cell-treated groups were translucent with a smooth and intact surface and less irregularity. In cell-treated group after 8 weeks post-transplantation, the overall healing score of experimental knees were superior when compared to other groups.Conclusion: We showed that Ad-MSCs, as an available and non-invasive produced source of cells, could be safely administered in knee osteochondral defects.</Abstract>
	</Article>
</ArticleSet>
